Zymeworks (ZYME) Assets Average (2022 - 2026)
Zymeworks (ZYME) reported Assets Average of $412.4 million for Q1 2026, down 7.19% on a YoY basis from $444.3 million in Q1 2025, and up 10.88% sequentially from $371.9 million in Q4 2025.
Zymeworks (ZYME) Assets Average (2022 - 2026) Analysis & Trends
Zymeworks (ZYME) has 5 years of Assets Average data on file, last reported at $412.4 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 7.19% year-over-year to $412.4 million; the trailing twelve-month figure through Mar 2026 stood at $412.4 million (down 7.19% YoY), and the FY2025 full-year result was $404.8 million, down 22.45% from the prior year.
- Assets Average advanced to $412.4 million in Q1 2026, from $371.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $624.7 million in Q1 2023 to a low of $371.9 million in Q4 2025.
- A 5-year average of $498.2 million and a median of $488.3 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average gained 19.84% in 2023 and decreased 22.02% in 2025, its largest moves.
- Tracing ZYME's Assets Average over 5 years: stood at $474.5 million in 2022, then grew by 19.84% to $568.6 million in 2023, then dropped by 16.44% to $475.1 million in 2024, then fell by 21.73% to $371.9 million in 2025, then increased by 10.88% to $412.4 million in 2026.
- Business Quant data shows ZYME's Assets Average at $412.4 million in Q1 2026, $371.9 million in Q4 2025, and $402.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 412.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 412.37 Mn |
| Dec 31, 2025 | 371.90 Mn |
| Sep 30, 2025 | 402.83 Mn |
| Jun 30, 2025 | 416.95 Mn |
| Mar 31, 2025 | 444.31 Mn |
| Dec 31, 2024 | 475.12 Mn |
| Sep 30, 2024 | 501.39 Mn |
| Jun 30, 2024 | 534.69 Mn |
| Mar 31, 2024 | 567.32 Mn |
| Dec 31, 2023 | 568.62 Mn |
| Sep 30, 2023 | 579.21 Mn |
| Jun 30, 2023 | 601.40 Mn |
| Mar 31, 2023 | 624.73 Mn |
| Dec 31, 2022 | 474.49 Mn |